Case Number:

IPR2017-02132

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Merck Sharp & Dohme Corp.

Patent Owner:

Pfizer Inc.

Patent Number:

9,492,559

Tech Center:

1600

1. Filed: September 19, 2017 00:00

   Coverage

   1. March 13, 2019

      Merck Gets PTAB To Nix Pfizer Vaccine Patent

      The Patent Trial and Appeal Board on Wednesday invalidated every claim of a Pfizer patent tied to next generation pneumonia vaccines, handing a win to rival Merck Sharp & Dohme Corp., which persuaded the board to ax a patent for a different pneumonia vaccine last year.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login